Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Pavan

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
European Journal of Medicinal Chemistry|December 10, 2022
Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growthDenise Sighel, Giulia Battistini, Emanuele Filiberto Rosatti, et al.
BMC Pediatrics|February 15, 2018
Measuring empathy in pediatrics: validation of the Visual CARE measureMichele Arigliani, Luigi Castriotta, Anna Pusiol, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Science Translational Medicine|October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
"Dual Anta-Inhibitors" of the A<sub>2A</sub> Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling StudiesAndrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
ACS Pharmacology & Translational Science|September 19, 2025
P2Y<sub>14</sub> Receptor Antagonists: Piperidine Bioisosteres and Mutagenesis-Supported Molecular ModelingAsmita Pramanik, Zhiwei Wen, Matteo Pavan, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Journal of Medicinal Chemistry|November 26, 2024
Potent and Selective Human 5-HT<sub>2B</sub> Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic SerendipityDilip K Tosh, Matteo Pavan, Allison A Clark, et al.
Plos Pathogens|September 11, 2024
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
European Journal of Medicinal Chemistry|December 10, 2022
Streptogramin A derivatives as mitochondrial translation inhibitors to suppress glioblastoma stem cell growthDenise Sighel, Giulia Battistini, Emanuele Filiberto Rosatti, et al.
BMC Pediatrics|February 15, 2018
Measuring empathy in pediatrics: validation of the Visual CARE measureMichele Arigliani, Luigi Castriotta, Anna Pusiol, et al.
ACS Pharmacology & Translational Science|July 18, 2024
2-Substituted (N)-Methanocarba A<sub>3</sub> Adenosine Receptor Agonists: In Silico, In Vitro, and In Vivo CharacterizationDilip K Tosh, Matteo Pavan, Chunxia Cronin, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Science Translational Medicine|October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
"Dual Anta-Inhibitors" of the A<sub>2A</sub> Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling StudiesAndrea Spinaci, Michela Buccioni, Daniela Catarzi, et al.
ACS Pharmacology & Translational Science|September 19, 2025
P2Y<sub>14</sub> Receptor Antagonists: Piperidine Bioisosteres and Mutagenesis-Supported Molecular ModelingAsmita Pramanik, Zhiwei Wen, Matteo Pavan, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Journal of Medicinal Chemistry|November 26, 2024
Potent and Selective Human 5-HT<sub>2B</sub> Serotonin Receptor Antagonists: 4'-Cyano-(N)-methanocarba-adenosines by Synthetic SerendipityDilip K Tosh, Matteo Pavan, Allison A Clark, et al.
Plos Pathogens|September 11, 2024
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based systemFrancesco Costacurta, Andrea Dodaro, David Bante, et al.
Pageof 6